🔗 Permalink

Inventor profile of:

Brigitte Grouix

City:

Montreal

Country:

Canada

Published Applications:

Last publication date:

2021-01-07

Top Assignees for applications by Brigitte Grouix

The entities that hold a legal rights for patent applications filed by inventor Grouix Brigitte:

PROMETIC PHARMA SMT LIMITED 5 Cambridge, United Kingdom
Prometic Pharma SMT Limited 2 Comberton, Cambridge, United Kingdom
PROMETIC BIOSCIENCES INC. 2 Laval, Quebec, Canada
LIMINAL BIOSCIENCES LIMITED 2 Cambridge, United Kingdom
Prometic Biosciences Inc. 1 Quebec, Canada
Prometic Biosciences Inc. 1 Mont-Royal, Canada
LIMINAL BIOSCIENCES LIMITED 1 Comberton, United Kingdom
Prometic Biosciences Inc. 1 Laval, Canada
ProMetic BioSciences Inc. 1 Montreal, Quebec, Canada

Recent patent applications by Grouix Brigitte

Brigitte Grouix from Montreal, CA has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2021-01-07

US20210002202A1

Chemistry; metallurgy

Substituted Aromatic Compounds and Pharmaceutical Uses Thereof

#2 | 2020-07-30

US20200237693A1

Human necessities

Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis

#3 | 2020-06-04

US20200172462A1

Chemistry; metallurgy

Substituted aromatic compounds and related method for the treatment of fibrosis

#4 | 2020-01-16

US20200017432A1

Chemistry; metallurgy

Substituted aromatic compounds for the treatment of pulmonary fibrosis, liver fibrosis, skin fibrosis and cardiac fibrosis

#5 | 2019-02-07

US20190038580A1

Human necessities

Phenylketone carboxylate compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis

#6 | 2018-08-23

US20180237374A1

Chemistry; metallurgy

Substituted aromatic compounds and related method for the treatment of fibrosis

#7 | 2018-08-16

US20180228750A1

Human necessities

SUBSTITUTED AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF OSTEOPOROSIS

#8 | 2018-06-14

US20180162799A1

Chemistry; metallurgy

Substituted aromatic compounds and pharmaceutical uses thereof

#9 | 2018-05-17

US20180134649A1

Chemistry; metallurgy

Substituted aromatic compounds for the treatment of pulmonary fibrosis, liver fibrosis, skin fibrosis and cardiac fibrosis

#10 | 2017-07-27

US20170209399A1

Human necessities

Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of diabetes

#11 | 2016-02-11

US20160039736A1

Chemistry; metallurgy

Substituted aromatic compounds and related method for the treatment of fibrosis

#12 | 2016-01-28

US20160023983A1

Chemistry; metallurgy

Substituted aromatic compounds for the treatment pulmonary fibrosis, liver fibrosis, skin fibrosis and cardiac fibrosis

#13 | 2013-08-29

US20130225681A1

Chemistry; metallurgy

Phenylketone carboxylate compounds and pharmaceutical uses thereof

#14 | 2013-08-22

US20130217645A1

Human necessities

Compounds and compositions for the treatment of cancer

#15 | 2010-05-27

US20100129350A1

Chemistry; metallurgy

Triazine derivatives, compositions containing such derivatives, and methods of treatment of cancer and autoimmune diseases using such derivatives

#16 | 2009-03-12

US20090068169A1

Chemistry; metallurgy

2,4,6-triamino-s-triazine-based compounds which bind to the tail (fc) portion of immunoglobulins and their use

#17 | 2007-06-28

US20070149528A1

Chemistry; metallurgy

Triazine dimers for the treatment of autoimmune diseases

InventorID:

403237 ⎘